These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8988092)

  • 1. Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke.
    Bednar MM; Gross CE; Russell SR; Short D; Giclas PC
    J Neurosurg; 1997 Jan; 86(1):139-42. PubMed ID: 8988092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil and Platelet Activity and Quantification Following Delayed tPA Therapy in a Rabbit Model of Thromboembolic Stroke.
    Bednar MM; Dooley RH; Zamani M; Howard DB; Gross CE
    J Thromb Thrombolysis; 1995; 1(2):179-185. PubMed ID: 10603528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of the spin trap agent disodium-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (generic NXY-059) in a rabbit small clot embolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.
    Lapchak PA; Araujo DM; Song D; Wei J; Zivin JA
    Stroke; 2002 May; 33(5):1411-5. PubMed ID: 11988623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
    Lapchak PA; Araujo DM; Song D; Zivin JA
    Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement depletion does not reduce brain injury in a rabbit model of thromboembolic stroke.
    Lew SM; Gross CE; Bednar MM; Russell SJ; Fuller SP; Ellenberger CL; Howard D
    Brain Res Bull; 1999 Feb; 48(3):325-31. PubMed ID: 10229342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dose tissue plasminogen activator.
    Lapchak PA; Zivin JA
    Stroke; 2003 Aug; 34(8):2013-8. PubMed ID: 12855833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
    Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
    J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of intra-arterial and intravenous tissue-type plasminogen activator on autologous arterial emboli in the cerebral circulation of rabbits.
    Hamilton MG; Lee JS; Cummings PJ; Zabramski JM
    Stroke; 1994 Mar; 25(3):651-5; discussion 656. PubMed ID: 8128521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator.
    Lapchak PA
    Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 16(R)-hydroxyeicosatetraenoic acid, a novel cytochrome P450 product of arachidonic acid, suppresses activation of human polymorphonuclear leukocyte and reduces intracranial pressure in a rabbit model of thromboembolic stroke.
    Bednar MM; Gross CE; Russell SR; Fuller SP; Ahern TP; Howard DB; Falck JR; Reddy KM; Balazy M
    Neurosurgery; 2000 Dec; 47(6):1410-8; discussion 1418-9. PubMed ID: 11126912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody to the ICAM-1 adhesion site reduces neurological damage in a rabbit cerebral embolism stroke model.
    Bowes MP; Zivin JA; Rothlein R
    Exp Neurol; 1993 Feb; 119(2):215-9. PubMed ID: 8094342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats.
    Meng W; Wang X; Asahi M; Kano T; Asahi K; Ackerman RH; Lo EH
    J Cereb Blood Flow Metab; 1999 Dec; 19(12):1316-21. PubMed ID: 10598935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenylpropanoid micronutrient chlorogenic acid improves clinical rating scores in rabbits following multiple infarct ischemic strokes: synergism with tissue plasminogen activator.
    Lapchak PA
    Exp Neurol; 2007 Jun; 205(2):407-13. PubMed ID: 17439814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.
    Thomas GR; Thibodeaux H; Errett CJ; Badillo JM; Keyt BA; Refino CJ; Zivin JA; Bennett WF
    Stroke; 1994 Oct; 25(10):2072-8; discussion 2078-9. PubMed ID: 8091454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination tissue plasminogen activator and ticlopidine therapy in a rabbit model of acute thromboembolic stroke.
    Bednar MM; Raymond-Russell SJ; Booth CL; Gross CE
    Neurol Res; 1996 Feb; 18(1):45-8. PubMed ID: 8714536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant tissue plasminogen activator in embolic stroke.
    Chehrazi BB; Seibert JA; Kissel P; Hein L; Brock JM
    Neurosurgery; 1989 Mar; 24(3):355-60. PubMed ID: 2494563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke.
    Gross CE; Raymond SJ; Howard DB; Bednar MM
    Neurosurgery; 1995 Jun; 36(6):1172-7. PubMed ID: 7643999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator extravasated through the cerebral vessels: evaluation using a rat thromboembolic stroke model.
    Harada T; Kano T; Katayama Y; Matsuzaki T; Tejima E; Koshinaga M
    Thromb Haemost; 2005 Oct; 94(4):791-6. PubMed ID: 16270632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.